Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2Porter's Five Force Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 PESTLE Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1. Drivers
4.1.1 Increasing research activities in RNAi technology mainly in cancer
4.2. Restraints
4.2.1 FDA regulations and reimbursement facilities
4.3 Opportunities
4.3.1 Rising demand for genetics-based on In-Vitro-Diagnostics
4.4 Challenges
4.4.1 Determining design for siRNA sequence and off-target effects.
Chapter 5 Global RNAi Technology Market - By Application
5.1 Agriculture
5.2 Research and development
5.3 Drug discovery
5.4 Therapeutics
5.4.1 Autoimmune Hepatitis
5.4.2 Ocular Disorders
5.4.3 Hepatitis B and C
5.4.4 Oncology
5.4.5 Respiratory Disorders
5.4.6 Heart ailments
5.4.7 Neurodegenerative disease
5.4.8 Others
Chapter 6 Global RNAi Technology Market - By Geography
6.1 Introduction
6.2 North America
6.2.1. The U.S.
6.2.2. Canada
6.2.3. Mexico
6.3 Europe
6.3.1. U.K.
6.3.2. Germany
6.3.3. France
6.3.4. Italy
6.3.5. Spain
6.3.6. Rest of Europe
6.4 Asia Pacific
6.4.1. China
6.4.2. Japan
6.4.3. India
6.4.3. Australia & New Zealand
6.4.5. South Korea
6.4.6. Rest of APAC
6.5 South America
6.5.1. Brazil
6.5.2. Argentina
6.5.3. Others
6.6. Middle East & Africa
6.6.1. Middle East
6.6.2. Africa
Chapter 7 Global RNAi Technology Market - Company Profiles
7.1. Thermo Fisher Scientific Inc.
7.2. Qiagen NV
7.3. Alnylam Pharmaceuticals
7.4. Merck & Co. Inc. (Sigma Aldrich)
7.5. Quark Pharmaceuticals Inc.
7.6. Ionis Pharmaceuticals Inc.
7.7. Arcturus Therapeutics
7.8. Silence Therapeutics
7.9. Pfizer Inc.
7.10. Benitec Biopharma Ltd
7.11 Takara Bio Inc. (Clonetch)
7.12 Invitrogen.
7.13 F. Hoffmann-La Roche Ag (Roche)
Chapter 8 Global RNAi Technology Market - Competitive Landscape
8.1. Market Share Analysis
8.2. Strategies Adopted by top companies
8.3. Mergers, Acquisitions, Collaborations & Agreements
Chapter 9 Market Insights
9.1. Industry Experts Insights
9.2. Analysts Opinions
9.3. Investment Opportunities
Chapter 10 Appendix
10.1 List of Tables
10.2 List of Figures
